drugset
drugset / Trial / NCT00917904

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

NCT00917904 ↗

Phase 1/2 Completed 100 enrolled International Partnership for Microbicides, Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine whether dapivirine gel 4789 is safe for daily use by healthy women in South Africa.

Timeline

Start
2009-07
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject dapivirine Small molecule 1.25 mg Other

Indications

AIDS